Denali Therapeutics Salaries & Compensation
Tech
Denali Therapeutics is a US-based biopharmaceutical company that develops therapeutic candidates for neurodegenerative diseases. Its product candidates include LRRK2 inhibitor, DNL310, DNL343, AR443820/DNL788, and SAR443122/DNL758. The company has collaboration agreements with various pharmaceutical companies and research institutions. It was formerly known as SPR Pharma Inc. and was incorporated in 2013.
Headquarters:South San Francisco, United States
Founded:2015
Employees:201-1,000
Type:public
Est. Revenue:$100M-$250M
4
Salary entries
$150K
Avg total comp
$125K
Median total comp
USD
Currency
Stats shown in USD (converted). Select a country for accurate local figures.
Headquarters